As per the new research report by RNCOS, “US Non-Invasive Prenatal Diagnostics - Market Insight”, the market for non-invasive prenatal diagnostics in US is expanding at a rapid rate, the latest entrant in the market being Illumina. Illumina has acquired Verinata Health for US$ 350 Million. Its entry into the market is expected to drastically modify the market landscape. Even Sequenom, the current leader in the NIPD market space, is dependent on Illumina’s next generation sequencing solutions for performing the tests. Further, two more players are expected to enter the US market in the next 5 years. With the dynamically evolving market landscape, possibilities are immense, making NIPD one of the most attractive markets in the maternal diagnostics sector.
The sector has a highly untapped potential and is expected that it will evolve greatly in the future. Research and innovation is very robust and several clinical trials are being performed to further support and expand the test’s offerings. Regulatory intervention is weak as NIPD tests are classified as Lab Developed Tests (LDTs) that do not require FDA regulation. Backed by such factors, the US NIPD market is expected to grow at a high CAGR of around 49% during 2012-2017.
The report provides an in-depth research and rational analysis of the current status and expected position of the US NIPD Market by 2017. Moreover, opportunity assessment for companies in the US NIPD Market in terms of leading technologies is also analyzed in the report. In addition, the report elaborates on the various restraints faced by the sector. To provide a holistic view, it also provides a competitive assessment of the major players describing their key business and comparing their strengths and weaknesses.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM450.htm
Some of our Related Reports are:
- Global Insulin Delivery Devices Market Forecast to 2017 (http://www.rncos.com/Report/IM494.htm)
- Genetic Testing Market Outlook to 2017 (http://www.rncos.com/Report/IM492.htm)
- Analysis of Coronary Stent in US (http://www.rncos.com/Report/IM489.htm)
- US Healthcare IT Market Outlook to 2017 (http://www.rncos.com/Report/IM487.htm)
- US Personalized Cancer Genome Sequencing Market (http://www.rncos.com/Report/IM453.htm)
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.